Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats - PubMed (original) (raw)
Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats
L Pozzi et al. J Neurochem. 1994 Jul.
Abstract
Experiments were performed to confirm that noradrenergic terminals regulate extracellular concentrations of dopamine (DA) in the frontal cortex of rats. The effects of 20 mg/kg 1-[2-[bis(4-fluorphenyl)methoxy]-ethyl]-4-(3- phenylpropyl)piperazine (GBR 12909), a selective inhibitor of DA uptake, and 2.5 mg/kg desipramine (DMI) on the extracellular concentrations of DA in the frontal cortex and striatum were studied in rats given 6-hydroxydopamine (6 micrograms/microliters) bilaterally into the locus coeruleus to destroy noradrenergic terminals. GBR 12909 increased dialysate DA similarly in the striatum of vehicle and 6-hydroxydopamine-treated rats, whereas in the frontal cortex it raised DA concentrations only in lesioned animals. DMI raised extracellular DA concentrations in the frontal cortex but not in the striatum of controls. The effect of DMI on cortical DA was abolished by the 6-hydroxydopamine lesion. GBR 12909, at a subcutaneous dose of 20 mg/kg, further increased cortical dialysate DA in rats given DMI intraperitoneally at 20 mg/kg or through the probe at 10(-5) mol/L. The data support the hypothesis of an important regulation of the extracellular concentrations of DA in the frontal cortex by noradrenergic terminals.
Similar articles
- The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H, Engberg G, Pileblad E. Nissbrandt H, et al. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):16-28. doi: 10.1007/BF00167378. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1663587 - Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
Devoto P, Flore G, Pira L, Longu G, Gessa GL. Devoto P, et al. J Neurochem. 2004 Feb;88(4):1003-9. doi: 10.1046/j.1471-4159.2003.02239.x. J Neurochem. 2004. PMID: 14756822 - Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers.
Di Chiara G, Tanda GL, Frau R, Carboni E. Di Chiara G, et al. Neurochem Int. 1992 Mar;20 Suppl:231S-235S. Neurochem Int. 1992. PMID: 1365432 - Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
Gálosi R, Petykó Z, Kállai V, Tóth A, Ollmann T, Péczely L, Kovács A, Berta B, Lénárd L. Gálosi R, et al. Behav Brain Res. 2018 May 15;344:57-64. doi: 10.1016/j.bbr.2018.02.016. Epub 2018 Feb 14. Behav Brain Res. 2018. PMID: 29454007 - Dopamine concentration in the cytoplasmic compartment of single neurons determined by capillary electrophoresis.
Olefirowicz TM, Ewing AG. Olefirowicz TM, et al. J Neurosci Methods. 1990 Sep;34(1-3):11-5. doi: 10.1016/0165-0270(90)90036-f. J Neurosci Methods. 1990. PMID: 2259233 Review.
Cited by
- Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals.
Sagheddu C, Devoto P, Aroni S, Saba P, Pistis M, Gessa GL. Sagheddu C, et al. Front Pharmacol. 2023 Aug 23;14:1238115. doi: 10.3389/fphar.2023.1238115. eCollection 2023. Front Pharmacol. 2023. PMID: 37680715 Free PMC article. - Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson's disease.
Kamińska K, Lenda T, Konieczny J, Lorenc-Koci E. Kamińska K, et al. Psychopharmacology (Berl). 2022 Nov;239(11):3633-3656. doi: 10.1007/s00213-022-06238-x. Epub 2022 Sep 30. Psychopharmacology (Berl). 2022. PMID: 36178508 Free PMC article. - Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.
Adeniran C, Yuan Y, Davis SE, Lin C, Xu J, Zhu J, Zhan CG. Adeniran C, et al. ACS Chem Neurosci. 2021 May 5;12(9):1519-1527. doi: 10.1021/acschemneuro.0c00792. Epub 2021 Apr 22. ACS Chem Neurosci. 2021. PMID: 33886267 Free PMC article. - Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex.
Devoto P, Sagheddu C, Santoni M, Flore G, Saba P, Pistis M, Gessa GL. Devoto P, et al. Front Pharmacol. 2020 Sep 23;11:588160. doi: 10.3389/fphar.2020.588160. eCollection 2020. Front Pharmacol. 2020. PMID: 33071798 Free PMC article. - Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?
Ranjbar-Slamloo Y, Fazlali Z. Ranjbar-Slamloo Y, et al. Front Mol Neurosci. 2020 Jan 21;12:334. doi: 10.3389/fnmol.2019.00334. eCollection 2019. Front Mol Neurosci. 2020. PMID: 32038164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous